Benoît Callendret

3.1k total citations · 2 hit papers
49 papers, 1.6k citations indexed

About

Benoît Callendret is a scholar working on Epidemiology, Infectious Diseases and Animal Science and Zoology. According to data from OpenAlex, Benoît Callendret has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 29 papers in Infectious Diseases and 10 papers in Animal Science and Zoology. Recurrent topics in Benoît Callendret's work include Respiratory viral infections research (25 papers), Viral gastroenteritis research and epidemiology (15 papers) and Viral Infections and Outbreaks Research (11 papers). Benoît Callendret is often cited by papers focused on Respiratory viral infections research (25 papers), Viral gastroenteritis research and epidemiology (15 papers) and Viral Infections and Outbreaks Research (11 papers). Benoît Callendret collaborates with scholars based in Netherlands, United States and Belgium. Benoît Callendret's co-authors include Christopher M. Walker, Christy Comeaux, Esther Heijnen, Arangassery Rosemary Bastian, William C. Satterfield, Nicolas Escriou, Els De Paepe, Heather B. Eccleston, Macaya Douoguih and Dana L. Hasselschwert and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Benoît Callendret

47 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries

2022 127 citations Jonathan S. Nguyen‐Van‐Tam, Maureen A. O’Leary et al. European Respiratory Review profile →
Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults

2023 90 citations Kristi L. Williams, Stephan Bart et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benoît Callendret Netherlands	20	893	751	432	299	163	49	1.6k
F. Xavier López‐Labrador Spain	23	1.4k 1.5×	307 0.4×	1.4k 3.3×	268 0.9×	43 0.3×	72	2.0k
Bernd Kupfer Germany	24	1.2k 1.4×	877 1.2×	971 2.2×	282 0.9×	92 0.6×	49	2.0k
Josep Costa Spain	29	2.4k 2.7×	575 0.8×	2.1k 5.0×	183 0.6×	112 0.7×	104	3.3k
Eva A. Operskalski United States	24	983 1.1×	816 1.1×	431 1.0×	300 1.0×	39 0.2×	42	2.1k
Sergei Viazov Germany	30	1.9k 2.1×	673 0.9×	1.9k 4.3×	286 1.0×	79 0.5×	76	2.8k
Greet J. Boland Netherlands	20	862 1.0×	236 0.3×	409 0.9×	380 1.3×	57 0.3×	64	1.5k
Jean‐Jacques Lefrère France	23	603 0.7×	646 0.9×	470 1.1×	121 0.4×	24 0.1×	81	1.6k
Victoria Kasprowicz United States	23	666 0.7×	558 0.7×	343 0.8×	742 2.5×	21 0.1×	44	1.7k
Sylvie Ranger‐Rogez France	24	912 1.0×	280 0.4×	281 0.7×	383 1.3×	47 0.3×	71	2.1k
Bianca Bruzzone Italy	23	850 1.0×	948 1.3×	471 1.1×	130 0.4×	31 0.2×	120	1.8k

Countries citing papers authored by Benoît Callendret

Since Specialization

Citations

This map shows the geographic impact of Benoît Callendret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoît Callendret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoît Callendret more than expected).

Fields of papers citing papers by Benoît Callendret

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoît Callendret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoît Callendret. The network helps show where Benoît Callendret may publish in the future.

Co-authorship network of co-authors of Benoît Callendret

This figure shows the co-authorship network connecting the top 25 collaborators of Benoît Callendret. A scholar is included among the top collaborators of Benoît Callendret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benoît Callendret. Benoît Callendret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tamura, Hiroshi, et al.. (2025). Phase 3 study of an Ad26.RSV.preF/RSV preF protein vaccine to evaluate the prevention efficacy of RSV-mediated lower tract disease, immunogenicity and safety in Japanese adults. Respiratory Investigation. 63(4). 560–568.

Salas, José A., Elizabeth Merrall, Erik Buntinx, et al.. (2024). Safety and immunogenicity of the Ad26/protein preF RSV vaccine in adults aged 18 to 59 years with and without at-risk comorbidities for severe respiratory syncytial virus disease: A phase 3, randomized, controlled, immunobridging trial. Vaccine. 43(Pt 1). 126514–126514. 4 indexed citations

Bastian, Arangassery Rosemary, et al.. (2024). Immunogenicity and safety of different dose levels of Ad26.RSV.preF/RSV preF protein vaccine in adults aged 60 years and older: A randomized, double-blind, placebo-controlled, phase 2a study. Vaccine. 42(26). 126273–126273. 3 indexed citations

Langley, Joanne M., Terry Nolan, Mika Rämet, et al.. (2024). A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12–24 Months. Open Forum Infectious Diseases. 11(9). ofae453–ofae453. 2 indexed citations

Eto, Takashi, Hiroshi Tamura, Richuan Zheng, et al.. (2024). A Randomized, Double‐Blind, Placebo‐Controlled, Phase 1 Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Single Vaccination of Ad26.RSV.preF‐Based Regimen in Japanese Adults Aged 60 Years and Older. Influenza and Other Respiratory Viruses. 18(6). e13336–e13336. 7 indexed citations

Saeland, Eiríkur, Leslie van der Fits, Lisanne Tettero, et al.. (2023). Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models. npj Vaccines. 8(1). 45–45. 11 indexed citations

Bastian, Arangassery Rosemary, Ilse Scheys, Els De Paepe, et al.. (2023). Concomitant Administration of Ad26.RSV.preF/RSV preF Protein Vaccine and High-Dose Influenza Vaccine in Adults 65 Years and Older: A Noninferiority Trial. The Journal of Infectious Diseases. 230(2). e374–e383. 5 indexed citations

Osborne, Richard H., Lauren Nelson, Sheri Fehnel, et al.. (2023). Evaluation of symptoms in respiratory syncytial virus infection in adults: psychometric evaluation of the Respiratory Infection Intensity and Impact Questionnaire™ symptom scores. Journal of Patient-Reported Outcomes. 7(1). 51–51. 5 indexed citations

Cox, Freek, Eiríkur Saeland, Lisanne Tettero, et al.. (2023). RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models. Vaccines. 11(3). 672–672. 6 indexed citations

10.

Bockstal, Viki, Georgi Shukarev, Chelsea McLean, et al.. (2022). First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study. PLoS ONE. 17(10). e0274906–e0274906. 19 indexed citations

11.

Nguyen‐Van‐Tam, Jonathan S., Maureen A. O’Leary, Emily T. Martin, et al.. (2022). Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries. European Respiratory Review. 31(166). 220105–220105. 127 indexed citations breakdown →

12.

Bockstal, Viki, Maarten Leyssen, Dirk Heerwegh, et al.. (2022). Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola. npj Vaccines. 7(1). 156–156. 13 indexed citations

13.

Potluri, Ravi, et al.. (2020). Impact of prophylactic vaccination strategies on Ebola virus transmission: A modeling analysis. PLoS ONE. 15(4). e0230406–e0230406. 19 indexed citations

14.

Escriou, Nicolas, Benoît Callendret, Valérie Lorin, et al.. (2014). Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein. Virology. 452-453. 32–41. 47 indexed citations

15.

Fuller, Michael J., Benoît Callendret, Baogong Zhu, et al.. (2013). Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1). Proceedings of the National Academy of Sciences. 110(37). 15001–15006. 140 indexed citations

16.

Callendret, Benoît & Christopher M. Walker. (2012). Will There Be a Vaccine to Protect Against the Hepatitis C Virus?. Gastroenterology. 142(6). 1384–1387. 4 indexed citations

17.

Callendret, Benoît & Christopher M. Walker. (2011). A siege of hepatitis: Immune boost for viral hepatitis. Nature Medicine. 17(3). 252–253. 19 indexed citations

18.

Fuller, Michael J., Naglaa H. Shoukry, David G. Bowen, et al.. (2009). Selection-Driven Immune Escape Is Not A Significant Factor in the Failure of Cd4 T Cell Responses in Persistent Hepatitis C Virus Infection. Hepatology. 51(2). 378–387. 54 indexed citations

19.

Uebelhoer, Luke S., Jin‐Hwan Han, Benoît Callendret, et al.. (2008). Stable Cytotoxic T Cell Escape Mutation in Hepatitis C Virus Is Linked to Maintenance of Viral Fitness. PLoS Pathogens. 4(9). e1000143–e1000143. 66 indexed citations

20.

Callendret, Benoît, Valérie Lorin, Pierre Charneau, et al.. (2007). Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS. Virology. 363(2). 288–302. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact